Current status:
Cancelled Post Market
Current status date:
2001-10-26
DIN:
00603791
Electronic product monograph is not available
Company:
GLAXO CANADA INC
7333 Mississauga Road N.
Mississauga
Ontario
Canada
L5N 6L4
Route(s) of administration:
Intramuscular
,
Intravenous
Number of active ingredient(s):
1
Anatomical Therapeutic Chemical (ATC):
See footnote 4
A02BA02 RANITIDINE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
RANITIDINE HYDROCHLORIDE
|
25 MG / ML
|